Physician profile
Saman Vojdani
NPI 1497172647
$23,786.37
in general payments reported to CMS, 2019-2025
27 companies · $5,100 in 2025
The $5,100 reported for 2025 was more than what 82% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $553 · 2020: $6,012 · 2021: $588 · 2022: $3,088 · 2023: $1,483 · 2024: $6,963 · 2025: $5,100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,250 · Food and Beverage: $5,012 · Long Term Medical Supply Or Device Loan: $2,459 · Education: $825.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,250.00 |
| Food and Beverage | $5,012.18 |
| Long Term Medical Supply Or Device Loan | $2,459.02 |
| Education | $824.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $9,673.19 | 2020-2025 | Real Intelligence, Journey II, Legion Revision |
| Linkbio Corp | $5,896.35 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $4,255.99 | 2023-2025 | Persona, G7, Rosa |
| Osteoremedies, LLC | $528.46 | 2024-2025 | Biobrush, Biowash Surgical Irrigation, Osteoboost Select 5cc |
| Maxx Orthopedics, INC. | $413.09 | 2024 | |
| Depuy Synthes Sales INC. | $333.86 | 2019-2020 | |
| Medical Device Business Services, INC. | $326.54 | 2019-2021 | |
| Stryker Corporation | $295.02 | 2019-2025 | Mako |
| Medacta USA, INC. | $294.08 | 2022-2024 | Mecta, Amistem |
| Arteriocyte Medical Systems, INC. | $230.99 | 2025 | Magellan |
| Becton, Dickinson and Company | $203.26 | 2024 | Arista Ah Flexitip |
| Pacira Pharmaceuticals Incorporated | $187.61 | 2023-2025 | Iovera, Exparel, Zilretta |
| Abbott Laboratories | $187.37 | 2024 | Proclaim |
| Microport Orthopedics INC | $171.13 | 2022 | |
| Heron Therapeutics, INC. | $167.81 | 2023-2025 | Zynrelef |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $158.55 | 2025 | Irrisept |
| Curonix LLC | $90.81 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Medtronic, INC. | $82.75 | 2023 | Intellis Adaptivestim |
| Vertex Pharmaceuticals Incorporated | $56.58 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $52.32 | 2024 | Euflexxa |
| Ossdsign USA Incorporated | $41.80 | 2025 | Ossdsign Catalyst |
| Solventum Corporation | $37.47 | 2024-2025 | Prevena, V.A.C. Veraflo Cleanse Choice, V.A.C.Ulta |
| Nalu Medical, INC. | $34.35 | 2024 | Nalu Neurostimulation System |
| Convatec INC. | $23.60 | 2025 | |
| Ethicon US, LLC | $18.73 | 2024 | Dermabond Prineo |
| Kuros Biosciences USA, INC | $15.11 | 2023 | |
| Heraeus Medical, LLC. | $9.55 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saman Vojdani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.